XML 55 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2018 13,977,868      
Balance at Dec. 31, 2018 $ 1,398 $ 85,599,140 $ (75,134,316) $ 10,466,222
Share-based compensation 509,528 509,528
Net loss (1,803,508) (1,803,508)
Issuance of common stock for directors’ fees (in shares) 13,820      
Issuance of common stock for directors’ fees $ 1 16,505 16,506
Balance (in shares) at Mar. 31, 2019 13,991,688      
Balance at Mar. 31, 2019 $ 1,399 86,125,173 (76,937,824) 9,188,748
Balance (in shares) at Dec. 31, 2019 14,411,432      
Balance at Dec. 31, 2019 $ 1,441 87,436,402 (89,723,016) (2,285,173)
Issuance of common stock pursuant to securities purchase agreements (in shares) 700,000      
Issuance of common stock pursuant to securities purchase agreements $ 70 1,032,430 1,032,500
Commitment fee adjustment (900,000) (900,000)
Beneficial conversion feature 641,215 641,215
Issuance of common stock pursuant to warrant conversion (in shares) 972,000      
Issuance of common stock pursuant to warrant conversion $ 97 1,457,903 1,458,000
Conversion of convertible note payable (in shares) 2,307,690      
Conversion of convertible note payable $ 231 1,499,769 1,500,000
Deemed dividends related to down-round features 112,686 (112,686)
Share-based compensation 512,719 512,719
Net loss (3,370,282) (3,370,282)
Balance (in shares) at Mar. 31, 2020 18,391,122      
Balance at Mar. 31, 2020 $ 1,839 $ 91,793,124 $ (93,205,984) $ (1,411,021)